{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:14:11Z","timestamp":1792084451308,"version":"4.4.0"},"reference-count":101,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:00:00Z","timestamp":1637193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Coronavirus Disease 2019 (COVID-19), during the second wave in early 2021, has caused devastating chaos in India. As daily infection rates rise alarmingly, the number of severe cases has increased dramatically. The country has encountered health infrastructure inadequacy and excessive demand for hospital beds, drugs, vaccines, and oxygen. Adding more burden to such a challenging situation, mucormycosis, an invasive fungal infection, has seen a sudden surge in patients with COVID-19. The rhino-orbital-cerebral form is the most common type observed. In particular, approximately three-fourths of them had diabetes as predisposing comorbidity and received corticosteroids to treat COVID-19. Possible mechanisms may involve immune and inflammatory processes. Diabetes, when coupled with COVID-19\u2013induced systemic immune change, tends to cause decreased immunity and an increased risk of secondary infections. Since comprehensive data on this fatal opportunistic infection are evolving against the backdrop of a major pandemic, prevention strategies primarily involve managing comorbid conditions in high-risk groups. The recommended treatment strategies primarily included surgical debridement and antifungal therapy using Amphotericin B and selected azoles. Several India-centric clinical guidelines have emerged to rightly diagnose the infection, characterise the clinical presentation, understand the pathogenesis involved, and track the disease course. Code Mucor is the most comprehensive one, which proposes a simple but reliable staging system for the rhino-orbital-cerebral form. A staging system has recently been proposed, and a dedicated registry has been started. In this critical review, we extensively analyse recent evidence and guidance on COVID-19\u2013associated mucormycosis in India.<\/jats:p>","DOI":"10.1371\/journal.pntd.0009921","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T14:01:07Z","timestamp":1637244067000},"page":"e0009921","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":116,"title":["COVID-19\u2013associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic\u2019s second wave in India"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-3252","authenticated-orcid":true,"given":"Jesil Mathew","family":"Aranjani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1158-0464","authenticated-orcid":true,"given":"Atulya","family":"Manuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3458-2219","authenticated-orcid":true,"given":"Habeeb Ibrahim","family":"Abdul Razack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam T.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,11,18]]},"reference":[{"key":"pntd.0009921.ref001","volume-title":"Coronavirus cases: India","author":"Worldometer","year":"2021"},{"key":"pntd.0009921.ref002","volume-title":"COVID-19 projections: India cumulative deaths","author":"IHME","year":"2021"},{"key":"pntd.0009921.ref003","unstructured":"MoHFW. Ministry of Health & Family Welfare. [cited 2021 Jul 17]. Government of India [Internet]. Available from: https:\/\/www.mohfw.gov.in\/."},{"key":"pntd.0009921.ref004","doi-asserted-by":"crossref","first-page":"003022282110087","DOI":"10.1177\/00302228211008753","article-title":"Understanding of Stigmatization and Death Amid COVID-19 in India: A Sociological Exploration","author":"S. Kumari","year":"2021","journal-title":"OMEGA\u2014J Death Dying"},{"issue":"10286","key":"pntd.0009921.ref005","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(21)01052-7","article-title":"India\u2019s COVID-19 emergency","volume":"397","author":"The Lancet","year":"2021","journal-title":"Lancet"},{"key":"pntd.0009921.ref006","volume-title":"India: Mass cremations begin as India\u2019s capital faces deluge of COVID-19 deaths","author":"D. Siddiqui","year":"2021"},{"key":"pntd.0009921.ref007","volume-title":"How India\u2019s second wave became the worst COVID-19 surge in the world","author":"N. Bhowmick","year":"2021"},{"key":"pntd.0009921.ref008","article-title":"COVID-19 and mucormycosis syndemic: double health threat to a collapsing healthcare system in India","author":"ICN Rocha","year":"2021","journal-title":"Tropical Med Int Health"},{"key":"pntd.0009921.ref009","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1017\/S0950268820001776","article-title":"COVID-19 in India: transmission dynamics, epidemiological characteristics, testing, recovery and effect of weather","volume":"148","author":"A. Chanda","year":"2020","journal-title":"Epidemiol Infect"},{"key":"pntd.0009921.ref010","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","author":"HE Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"pntd.0009921.ref011","first-page":"20499361211027065","article-title":"COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs","volume":"8","author":"AJ Rodriguez-Morales","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"pntd.0009921.ref012","doi-asserted-by":"crossref","first-page":"102195","DOI":"10.1016\/j.dsx.2021.102195","article-title":"Diabetes mellitus and Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): A wake-up call from Egypt","author":"M Alfishawy","year":"2021","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"5","key":"pntd.0009921.ref013","doi-asserted-by":"crossref","first-page":"e0251170","DOI":"10.1371\/journal.pone.0251170","article-title":"Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis","volume":"16","author":"JS Musuuza","year":"2021","journal-title":"PLoS ONE"},{"key":"pntd.0009921.ref014","article-title":"Intercepting the deadly trinity of mucormycosis, diabetes and COVID-19 in India","author":"M Banerjee","year":"2021","journal-title":"Postgrad Med J."},{"key":"pntd.0009921.ref015","article-title":"Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave?","author":"A Raut","year":"2021","journal-title":"Lancet Respir Med"},{"key":"pntd.0009921.ref016","article-title":"The recent mucormycosis storm over Indian sky","author":"A. Chakrabarti","year":"2021","journal-title":"Indian J Med Microbiol"},{"key":"pntd.0009921.ref017","article-title":"Current Understanding in the Pathophysiology of SARS-CoV-2-Associated Rhino-Orbito-Cerebral Mucormycosis: A Comprehensive Review","author":"A Jose","year":"2021","journal-title":"J Maxillofac Oral Surg."},{"issue":"3","key":"pntd.0009921.ref018","doi-asserted-by":"crossref","first-page":"101161","DOI":"10.1016\/j.mycmed.2021.101161","article-title":"Mucormycosis: A killer in the shadow of COVID-19","volume":"31","author":"TK Suvvari","year":"2021","journal-title":"J Mycol Med"},{"key":"pntd.0009921.ref019","article-title":"The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis","author":"K Ahmadikia","year":"2021","journal-title":"Mycoses"},{"issue":"4","key":"pntd.0009921.ref020","doi-asserted-by":"crossref","first-page":"102177","DOI":"10.1016\/j.dsx.2021.06.014","article-title":"Mass urine sugar testing to tackle post-COVID mucormycosis epidemic in India-MUSTARD concept","volume":"15","author":"P Garg","year":"2021","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"issue":"S1","key":"pntd.0009921.ref021","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2021.35.S1.04770","article-title":"Mucormycosis In Post Covid Patients: A Systematic Review","volume":"35","author":"A Agarwal","year":"2021","journal-title":"FASEB J"},{"issue":"2","key":"pntd.0009921.ref022","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature","volume":"186","author":"D Garg","year":"2021","journal-title":"Mycopathologia"},{"key":"pntd.0009921.ref023","article-title":"COVID-19-associated mucormycosis: An updated systematic review of literature","author":"R Pal","year":"2021","journal-title":"Mycoses"},{"issue":"4","key":"pntd.0009921.ref024","doi-asserted-by":"crossref","first-page":"102146","DOI":"10.1016\/j.dsx.2021.05.019","article-title":"Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India","volume":"15","author":"AK Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"9","key":"pntd.0009921.ref025","doi-asserted-by":"crossref","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India","volume":"27","author":"A Patel","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"pntd.0009921.ref026","volume-title":"Mucormycosis\u2014Black Fungus: Daily Dashboard\u2014Total Cases for India","author":"GovernmentStats","year":"2021"},{"issue":"1","key":"pntd.0009921.ref027","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"W Jeong","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"pntd.0009921.ref028","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s42399-021-00873-9","article-title":"Fungal Infections of Oral Cavity: Diagnosis, Management, and Association with COVID-19","volume":"3","author":"AB Rajendra Santosh","year":"2021","journal-title":"SN Compr Clin Med."},{"issue":"4","key":"pntd.0009921.ref029","article-title":"Epidemiology and Diagnosis of Mucormycosis: An Update","volume":"6","author":"A Skiada","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"pntd.0009921.ref030","volume-title":"Calling Mucormycosis \u2018Black Fungus\u2019 is a misnomer, says Dr Venkatesh Prajna","author":"L. Srikrishna","year":"2021"},{"issue":"7","key":"pntd.0009921.ref031","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4103\/ijo.IJO_1392_21","article-title":"The emergence of post-COVID-19 mucormycosis in India: Can we prevent it?","volume":"69","author":"A Gupta","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"pntd.0009921.ref032","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/myc.12243","article-title":"Mucormycosis in India: unique features","volume":"57","author":"A Chakrabarti","year":"2014","journal-title":"Mycoses"},{"issue":"6","key":"pntd.0009921.ref033","first-page":"769","article-title":"Isolated bilateral renal mucormycosis in apparently immunocompetent patients-a case series from India and review of the literature","volume":"11","author":"D Bhadauria","year":"2018","journal-title":"Clin Kidney J"},{"issue":"7","key":"pntd.0009921.ref034","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India\u2014Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"M Sen","year":"2021","journal-title":"Indian J Ophthalmol."},{"key":"pntd.0009921.ref035","volume-title":"Diagnosis and management of COVID-19 associated mucormycosis (CAM): Fact sheet from CIDS","author":"CIDS"},{"issue":"8","key":"pntd.0009921.ref036","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1007\/s00405-021-06932-0","article-title":"Black fungus and COVID-19: role of otorhinolaryngologists and audiologists","volume":"278","author":"AF Raza","year":"2021","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"pntd.0009921.ref037","doi-asserted-by":"crossref","first-page":"100722","DOI":"10.1016\/j.jemep.2021.100722","article-title":"Delta variant and black fungal invasion: A bidirectional assault might worsen the massive second\/third stream of COVID-19 outbreak in South-Asia","volume":"19","author":"MS Bari","year":"2021","journal-title":"Ethics Med Public Health"},{"issue":"9","key":"pntd.0009921.ref038","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S2213-2600(21)00312-X","article-title":"Implications of the second wave of COVID-19 in India","volume":"9","author":"P Asrani","year":"2021","journal-title":"Lancet Respir Med"},{"key":"pntd.0009921.ref039","article-title":"Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World","author":"V Muthu","year":"2021","journal-title":"Mycopathologia"},{"issue":"6","key":"pntd.0009921.ref040","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.4103\/ijo.IJO_310_21","article-title":"Rise of the phoenix: Mucormycosis in COVID-19 times","volume":"69","author":"SA Ravani","year":"2021","journal-title":"Indian J Ophthalmol."},{"issue":"2","key":"pntd.0009921.ref041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12663-021-01547-8","article-title":"COVID-19 and Mucormycosis of the Craniofacial skeleton: Causal, Contributory or Coincidental?","volume":"20","author":"DK Verma","year":"2021","journal-title":"J Maxillofac Oral Surg."},{"key":"pntd.0009921.ref042","volume-title":"COVID-19 infection and rhino-orbito-cerebral mucromycosis: Treatment organisation & guidance","author":"AIIMS","year":"2021"},{"key":"pntd.0009921.ref043","volume-title":"Screening, diagnosis & management of mucormycosis: Evidence based advisory in the time of COVID-19","author":"ICMR","year":"2021"},{"issue":"10","key":"pntd.0009921.ref044","doi-asserted-by":"crossref","first-page":"784.e727","DOI":"10.1016\/j.crad.2021.07.002","article-title":"Imaging findings using a combined MRI\/CT protocol to identify the \u201centire iceberg\u201d in post-COVID-19 mucormycosis presenting clinically as only \u201cthe tip\u201d","volume":"76","author":"SM Desai","year":"2021","journal-title":"Clin Radiol"},{"issue":"7","key":"pntd.0009921.ref045","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.4103\/ijo.IJO_1439_21","article-title":"Magnetic resonance imaging in rhino-orbital-cerebral mucormycosis","volume":"69","author":"K Sreshta","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"pntd.0009921.ref046","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.4103\/ijo.IJO_1506_21","article-title":"The \"black fungus\" through a gray lens: Imaging COVID-19-associated mucormycosis","volume":"69","author":"CP Nagesh","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"pntd.0009921.ref047","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.15190\/d.2021.5","article-title":"High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections","volume":"9","author":"K Bhatt","year":"2021","journal-title":"Discoveries (Craiova)"},{"issue":"4","key":"pntd.0009921.ref048","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"S Sarkar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"pntd.0009921.ref049","doi-asserted-by":"crossref","first-page":"110613","DOI":"10.1016\/j.mehy.2021.110613","article-title":"Does COVID 19 generate a milieu for propagation of mucormycosis?","volume":"152","author":"D Pandiar","year":"2021","journal-title":"Med Hypotheses"},{"key":"pntd.0009921.ref050","article-title":"The surge in Covid related mucormycosis","author":"S Chandra","year":"2021","journal-title":"J Infect."},{"key":"pntd.0009921.ref051","first-page":"1","article-title":"Mucormycosis of Paranasal Sinuses of Odontogenic Origin Post COVID19 Infection: A Case Series","author":"PK Saidha","year":"2021","journal-title":"Indian J Otolaryngol Head Neck Surg."},{"issue":"4","key":"pntd.0009921.ref052","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10384-021-00845-5","article-title":"Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations","volume":"65","author":"N Bayram","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"pntd.0009921.ref053","volume-title":"World population prospects 2019 (median-fertility variant)","author":"UN"},{"issue":"12","key":"pntd.0009921.ref054","doi-asserted-by":"crossref","first-page":"e1352","DOI":"10.1016\/S2214-109X(18)30387-5","article-title":"India State-Level Disease Burden Initiative Diabetes Collaborators: The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990\u20132016","volume":"6","author":"ISLDBIDC","year":"2018","journal-title":"Lancet Glob Health"},{"key":"pntd.0009921.ref055","article-title":"Mucormycosis-A serious threat in the COVID-19 pandemic?","author":"L Szarpak","year":"2021","journal-title":"J Infect."},{"issue":"5","key":"pntd.0009921.ref056","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum","volume":"135","author":"S Sharma","year":"2021","journal-title":"J Laryngol Otol"},{"issue":"4","key":"pntd.0009921.ref057","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/ijp.ijp_419_21","article-title":"Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review","volume":"53","author":"A Bhattacharyya","year":"2021","journal-title":"Indian J Pharm."},{"issue":"4","key":"pntd.0009921.ref058","first-page":"e2021271","article-title":"Rising concerns of Mucormycosis (Zygomycosis) among COVID-19 patients; an analysis and review based on case reports in literature","volume":"92","author":"K Ramphul","year":"2021","journal-title":"Acta Biomed"},{"issue":"5","key":"pntd.0009921.ref059","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/IOP.0000000000002030","article-title":"Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study","volume":"37","author":"TV Dave","year":"2021","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"7","key":"pntd.0009921.ref060","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.4103\/ijo.IJO_1143_21","article-title":"COVID-19, steroids, and mucormycosis: What an ophthalmologist should know","volume":"69","author":"A Tandon","year":"2021","journal-title":"Indian J Ophthalmol."},{"key":"pntd.0009921.ref061","volume-title":"Doctors have been blamed for the rise in black fungus in India, but the COVID treatment guidelines could be contributing","author":"R. Dasgupta","year":"2021"},{"key":"pntd.0009921.ref062","article-title":"COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease","author":"S Narayanan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"pntd.0009921.ref063","doi-asserted-by":"crossref","first-page":"106031","DOI":"10.1016\/j.ijsu.2021.106031","article-title":"Mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum","volume":"92","author":"P Devnath","year":"2021","journal-title":"Int J Surg"},{"issue":"4","key":"pntd.0009921.ref064","doi-asserted-by":"crossref","first-page":"102196","DOI":"10.1016\/j.dsx.2021.102196","article-title":"Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India","volume":"15","author":"Y Mishra","year":"2021","journal-title":"Diabetes Metab Syndr."},{"issue":"7","key":"pntd.0009921.ref065","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.4103\/ijo.IJO_1200_21","article-title":"Prevention of mucormycosis in COVID-19\u2014the need of the hour","volume":"69","author":"P Ish","year":"2021","journal-title":"Indian J Ophthalmol."},{"key":"pntd.0009921.ref066","doi-asserted-by":"crossref","first-page":"101597","DOI":"10.1016\/j.bjid.2021.101597","article-title":"Is Mucormycosis an inevitable complication of Covid-19 in India?","author":"R Bhogireddy","year":"2021","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"pntd.0009921.ref067","doi-asserted-by":"crossref","DOI":"10.1186\/s43163-021-00121-w","article-title":"COVID 19 infection and mucormycosis\u2014a dangerously increasing combination","volume":"37","author":"SS Bakshi","year":"2021","journal-title":"Egypt J Otolaryngol."},{"key":"pntd.0009921.ref068","article-title":"\"Black fungus\": a perspective on the coronavirus disease 2019 (COVID-19)-associated rhino-orbital mucormycosis epidemic in India","author":"A Thakar","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"10","key":"pntd.0009921.ref069","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/myc.13365","article-title":"Is there an association between zinc and COVID-19\u2013associated mucormycosis? Results of an experimental and clinical study","volume":"64","author":"V Muthu","year":"2021","journal-title":"Mycoses"},{"key":"pntd.0009921.ref070","article-title":"Mucormycosis or black fungus infection is a new scare in South Asian countries during the COVID-19 pandemic: Associated risk factors and preventive measures","author":"FI Rahman","journal-title":"J Med Virol"},{"key":"pntd.0009921.ref071","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/tid.13652","article-title":"Mucormycosis associated with COVID-19 in two kidney transplant patients","author":"C Arana","year":"2021","journal-title":"Transpl Infect Dis."},{"key":"pntd.0009921.ref072","doi-asserted-by":"crossref","first-page":"e13663","DOI":"10.1111\/tid.13663","article-title":"Mucormycosis in post-COVID-19 renal transplant patients: A lethal complication in follow-up","author":"HS Meshram","year":"2021","journal-title":"Transpl Infect Dis."},{"key":"pntd.0009921.ref073","article-title":"COVID-19 associated mucormycosis: An epidemic within a pandemic","author":"R Sarda","year":"2021","journal-title":"QJM"},{"key":"pntd.0009921.ref074","doi-asserted-by":"crossref","first-page":"100153","DOI":"10.1016\/j.puhip.2021.100153","article-title":"Mucormycosis or black fungus is a new fright in India during covid-19 pandemic: Associated risk factors and actionable items","volume":"2","author":"AA Moona","year":"2021","journal-title":"Public Health Pract (Oxf)."},{"issue":"5","key":"pntd.0009921.ref075","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/hpm.3257","article-title":"The use of cow dung and urine to cure COVID-19 in India: A public health concern","volume":"36","author":"S Daria","year":"2021","journal-title":"Int J Health Plann Manag."},{"issue":"6","key":"pntd.0009921.ref076","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code Mucor: Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"SG Honavar","year":"2021","journal-title":"Indian J Ophthalmol."},{"issue":"12","key":"pntd.0009921.ref077","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"OA Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"pntd.0009921.ref078","article-title":"ECMM\/ISHAM recommendations for clinical management of COVID -19 associated mucormycosis in low- and middle-income countries","author":"SM Rudramurthy","year":"2021","journal-title":"Mycoses"},{"key":"pntd.0009921.ref079","volume-title":"Mucormycosis: guidelines for the diagnosis and management","author":"IMA"},{"key":"pntd.0009921.ref080","volume-title":"Guideline for management of mucormycosis in COVID-19 patients","author":"DGHS"},{"key":"pntd.0009921.ref081","volume-title":"COVID-19 associated mucormycosis (CAM)","author":"FISF","year":"2021"},{"key":"pntd.0009921.ref082","volume-title":"Technical guideline on diagnosis and treatment of COVID-19 associated mucormycosis (CAM)","author":"KSHFWD","year":"2021"},{"key":"pntd.0009921.ref083","volume-title":"Advisory in the time of COVID-19: Screening, diagnosis & management of mucormycosis","author":"NHM-HP","year":"2021"},{"key":"pntd.0009921.ref084","volume-title":"Key facts: Mucormycosis","author":"WHO"},{"key":"pntd.0009921.ref085","volume-title":"FDA Adverse Events Reporting System\u2014Public dashboard","author":"FAERS","year":"2021"},{"key":"pntd.0009921.ref086","volume-title":"The Liverpool Drug Interaction Group: Prescribing resources: COVID-19 drug interations\u2014Detailed recommendations for interactions with experimental COVID-19 antiviral and immune therapies","author":"TLDIG","year":"2021"},{"issue":"2","key":"pntd.0009921.ref087","first-page":"117","article-title":"Mucormycosis in head and neck area\u2014the emerging health problem in COVID-19 pandemic. The perspective of a dental practitioner","volume":"61","author":"M Pasternak","year":"2021","journal-title":"Folia Med Cracov."},{"issue":"1","key":"pntd.0009921.ref088","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/ijdr.ijdr_594_21","article-title":"Dental surveillance for Post-COVID mucormycosis","volume":"32","author":"S. Balaji","year":"2021","journal-title":"Indian J Dent Res"},{"issue":"4","key":"pntd.0009921.ref089","doi-asserted-by":"crossref","first-page":"102169","DOI":"10.1016\/j.dsx.2021.06.006","article-title":"Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit","volume":"15","author":"B Mulakavalupil","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"pntd.0009921.ref090","volume-title":"Mucormycosis in COVID-19 (MUNCO) (Sponsor: Montefiore Medical Center)","author":"NCT04935463","year":"2021"},{"key":"pntd.0009921.ref091","volume-title":"Coronavirus disease-associated mucormycosis warrants timely collaborative registers","author":"S Arora","year":"2021"},{"key":"pntd.0009921.ref092","volume-title":"Mycotic infections in COVID-19 reporting database","author":"MUNCO"},{"issue":"8","key":"pntd.0009921.ref093","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/myc.12631","article-title":"FungiScope(\u2122) -Global Emerging Fungal Infection Registry","volume":"60","author":"D Seidel","year":"2017","journal-title":"Mycoses"},{"key":"pntd.0009921.ref094","volume-title":"Global registry for emerging fungal infections","author":"FungiScope"},{"key":"pntd.0009921.ref095","volume-title":"Characterization of fungal infections in COVID-19 infected and mechanically ventilated patients in ICU (MY-CO-VID) (Sponsor: Rennes University Hospital)","author":"NCT04368221","year":"2021"},{"key":"pntd.0009921.ref096","article-title":"Mucormycosis and glucose-regulated protein 78 in COVID-19: amenable to statin treatment?","author":"A Vuorio","year":"2021","journal-title":"J Intern Med"},{"issue":"4","key":"pntd.0009921.ref097","doi-asserted-by":"crossref","first-page":"102162","DOI":"10.1016\/j.dsx.2021.05.035","article-title":"Should statins be considered for the management of mucormycosis in COVID-19?","volume":"15","author":"S Chatterjee","year":"2021","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"pntd.0009921.ref098","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw1327","article-title":"Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosis, eaaw1327","volume":"5","author":"T Gebremariam","year":"2019","journal-title":"Sci Adv."},{"issue":"3","key":"pntd.0009921.ref099","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01087-20","article-title":"GRP78 and Integrins Play Different Roles in Host Cell Invasion during Mucormycosis","volume":"11","author":"A Alqarihi","year":"2020","journal-title":"mBio"},{"issue":"3","key":"pntd.0009921.ref100","doi-asserted-by":"crossref","first-page":"101007","DOI":"10.1016\/j.mycmed.2020.101007","article-title":"Mucormycosis treatment: Recommendations, latest advances, and perspectives","volume":"30","author":"K Brunet","year":"2020","journal-title":"J Mycol Med"},{"issue":"5","key":"pntd.0009921.ref101","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1108\/RPJ-01-2017-0003","article-title":"Gagandeep, Aneesh, Rattan V, Luthra G, Kalra P. Development of a custom zygomatic implant using metal sintering","volume":"24","author":"VK Meena","year":"2018","journal-title":"Rapid Prototyp J"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T11:59:13Z","timestamp":1726142353000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009921"}},"subtitle":[],"editor":[{"given":"Susanna Kar Pui","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,18]]},"references-count":101,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009921","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,18]]}}}